Manufacture

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

How is the field of antibody drug conjugates being reshaped?

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

Applying mRNA technology to the treatment of malaria.

Could mRNA vaccine be the flu interventions of tomorrow?

We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.

Defining the best strategies for working with highly potent drug substances.

Embracing the benefits of auto-injectors.

What milestones will define the next era in the mRNA story?